The detailed inhibitor study of inactivation of membrane-associated catalase after CAP and PAM-treatment revealed that long-lived species derived from CAP/PAM are essential and sufficient to initiate this process, but that the generation of tumor cell-derived secondary 1O2 is the dominant mechanism to inactivate catalase under standard conditions of our experiments. This evidence concerns the gene CAT and neoplasm.